OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Viktoria Florentine Koehler, Josefine Achterfeld, N. Sandner, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 14035-14043
Open Access | Times Cited: 8
Viktoria Florentine Koehler, Josefine Achterfeld, N. Sandner, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 14035-14043
Open Access | Times Cited: 8
Showing 8 citing articles:
NTRK Fusion–Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Vicente Rodrigues Marczyk, Sasan Fazeli, Ramona Dadu, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access | Times Cited: 1
Vicente Rodrigues Marczyk, Sasan Fazeli, Ramona Dadu, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access | Times Cited: 1
Clinicopathological analysis of thyroid carcinomas with the RET and NTRK fusion genes: characterization for genetic analysis
Yoichiro Okubo, Soji Toda, Mei Kadoya, et al.
Virchows Archiv (2024) Vol. 485, Iss. 3, pp. 509-518
Open Access | Times Cited: 3
Yoichiro Okubo, Soji Toda, Mei Kadoya, et al.
Virchows Archiv (2024) Vol. 485, Iss. 3, pp. 509-518
Open Access | Times Cited: 3
A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions
Isabella Tondi Resta, Ali Hamza Rind, Kathleen T. Montone, et al.
Human Pathology (2024) Vol. 149, pp. 29-38
Closed Access | Times Cited: 1
Isabella Tondi Resta, Ali Hamza Rind, Kathleen T. Montone, et al.
Human Pathology (2024) Vol. 149, pp. 29-38
Closed Access | Times Cited: 1
Schilddrüsenkarzinome – Rolle internistischer Systemtherapien
Tim Brandenburg, Matthias Kroiß
Deleted Journal (2024) Vol. 65, Iss. 7, pp. 642-655
Closed Access | Times Cited: 1
Tim Brandenburg, Matthias Kroiß
Deleted Journal (2024) Vol. 65, Iss. 7, pp. 642-655
Closed Access | Times Cited: 1
Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer
Silvia Martina Ferrari, Armando Patrizio, Giulio Stoppini, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 12, pp. 1667-1676
Closed Access | Times Cited: 1
Silvia Martina Ferrari, Armando Patrizio, Giulio Stoppini, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 12, pp. 1667-1676
Closed Access | Times Cited: 1
Larotrectinib/lenvatinib/selitrectinib
Reactions Weekly (2024) Vol. 2003, Iss. 1, pp. 494-494
Closed Access
Reactions Weekly (2024) Vol. 2003, Iss. 1, pp. 494-494
Closed Access
Larotrectinib efficacy for liver metastases in papillary thyroid carcinoma patient harboring SQSTM1–NTRK1 fusion
Haruhiko Yamazaki, Makoto Sugimori, Aya Saito
Surgical Case Reports (2024) Vol. 10, Iss. 1
Open Access
Haruhiko Yamazaki, Makoto Sugimori, Aya Saito
Surgical Case Reports (2024) Vol. 10, Iss. 1
Open Access
Single Institution Experience of Larotrectinib Therapy for Patients with NTRK Fusion Positive Thyroid Carcinoma
Omar Elghawy, Adam Barsouk, Alec Heidlauf, et al.
Journal of the Endocrine Society (2024) Vol. 8, Iss. 10
Open Access
Omar Elghawy, Adam Barsouk, Alec Heidlauf, et al.
Journal of the Endocrine Society (2024) Vol. 8, Iss. 10
Open Access
